Skip to main content
/
Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.65
-11.75 (-25.88%)
Apr 7, 2025, 4:09 PM HKT

HKG:6855 Revenue

In the year 2024, Ascentage Pharma Group International had annual revenue of 980.65M CNY with 341.77% growth. Ascentage Pharma Group International had revenue of 156.90M in the half year ending December 31, 2024, with 37.70% growth.

Revenue
980.65M CNY
Revenue Growth
+341.77%
P/S Ratio
9.74
Revenue / Employee
1.68M CNY
Employees
583
Market Cap
11.53B HKD

Revenue Chart

Created with Highcharts 11.4.8HKG:6855 Revenue - Annual12.45M​12.45M27.91M​27.91M209.7M​209.7M222.0M​222.0M980.7M​980.7M20202021202220232024-250M500M750M1B
* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024980.65M758.67M341.77%
Dec 31, 2023221.98M12.27M5.85%
Dec 31, 2022209.71M181.80M651.38%
Dec 31, 202127.91M15.46M124.18%
Dec 31, 202012.45M-2.06M-14.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeiGene 29.60B
Hansoh Pharmaceutical Group Company 13.05B
JD Health International 61.89B
WuXi Biologics 19.87B
Innovent Biologics 10.03B
Akeso 2.26B
Alibaba Health Information Technology 31.39B
Sichuan Kelun-Biotech Biopharmaceutical 2.06B
Revenue Rankings

Ascentage Pharma Group International News

More News